ResMed (ASX:RMD) share price in focus after FY24 Q1 update
After plenty of volatility for the ResMed Inc (ASX:RMD) share price, the healthcare company has released its FY24 first quarter update.
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
After plenty of volatility for the ResMed Inc (ASX:RMD) share price, the healthcare company has released its FY24 first quarter update.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.61% to 6812.30.
The benchmark S&P/ASX 200 (INDEXASX: XJO) closed 2.6 points lower, at 6,854, losing early gains. The broader All Ordinaries (INDEXASX: XAO) index, however, managed a 0.7-point gain, to 7,046.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.038% to 6854.30.
We pull apart the remaining ASX shares from last week, including Cochlear Limited (ASX: COH), Macquarie Group Ltd (ASX: MQG) and more.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.19% to 6856.90.
The Australian stock market has given up all of the gains that it had made in 2023, with the benchmark S&P/ASX 200 (INDEXASX: XJO) losing 56.6 points, or 0.8%, on Monday to 6,844.1, with resources weakness the major culprit. That puts the index in the red by 2.8% for the year.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.82% to 6844.10.
The Pro Medicus Ltd (ASX: PME) share price has risen after revealing another solid contract win in Australia.
After plenty of volatility for the ResMed Inc (ASX:RMD) share price, the healthcare company has released its FY24 first quarter update.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.61% to 6812.30.
The benchmark S&P/ASX 200 (INDEXASX: XJO) closed 2.6 points lower, at 6,854, losing early gains. The broader All Ordinaries (INDEXASX: XAO) index, however, managed a 0.7-point gain, to 7,046.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.038% to 6854.30.
We pull apart the remaining ASX shares from last week, including Cochlear Limited (ASX: COH), Macquarie Group Ltd (ASX: MQG) and more.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.19% to 6856.90.
The Australian stock market has given up all of the gains that it had made in 2023, with the benchmark S&P/ASX 200 (INDEXASX: XJO) losing 56.6 points, or 0.8%, on Monday to 6,844.1, with resources weakness the major culprit. That puts the index in the red by 2.8% for the year.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.82% to 6844.10.
The Pro Medicus Ltd (ASX: PME) share price has risen after revealing another solid contract win in Australia.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.